ArticleInternational journal of urology : official journal of the Japanese Urological Association2022
Editorial Comment to Phase II trial of nivolumab monotherapy and biomarker screening in patients with chemo-refractory germ cell tumors.
Finn-Ole Paulsen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.